4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide

C33H35N5O3 — CID 98442536

IUPAC4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide
SMILESCOc1ccc(C(=O)N(CC(=O)N2CCN(c3ccc(-c4ccc(C)cc4)nn3)CC2)[C@@H](C)c2ccccc2)cc1
InChIInChI=1S/C33H35N5O3/c1-24-9-11-27(12-10-24)30-17-18-31(35-34-30)36-19-21-37(22-20-36)32(39)23-38(25(2)26-7-5-4-6-8-26)33(40)28-13-15-29(41-3)16-14-28/h4-18,25H,19-23H2,1-3H3/t25-/m0/s1
InChIKeyKRSDRRVVBOOERJ-VWLOTQADSA-N
MW549.68 g/mol
LogP5.01
Rot. Bonds8

About 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide

4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide (PubChem CID 98442536) has the molecular formula C33H35N5O3 and a molecular weight of 549.68 g/mol. Its IUPAC name is 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide.

Molecular Properties

Compound Name4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide
PubChem CID98442536
Molecular FormulaC33H35N5O3
Molecular Weight549.68 g/mol
Exact Mass549.27
IUPAC Name4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide
SMILESCOc1ccc(C(=O)N(CC(=O)N2CCN(c3ccc(-c4ccc(C)cc4)nn3)CC2)[C@@H](C)c2ccccc2)cc1
InChIInChI=1S/C33H35N5O3/c1-24-9-11-27(12-10-24)30-17-18-31(35-34-30)36-19-21-37(22-20-36)32(39)23-38(25(2)26-7-5-4-6-8-26)33(40)28-13-15-29(41-3)16-14-28/h4-18,25H,19-23H2,1-3H3/t25-/m0/s1
InChIKeyKRSDRRVVBOOERJ-VWLOTQADSA-N
XLogP5.01
TPSA78.87 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds8
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500549.68
LogP ≤ 55.01
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide?
The IUPAC name of 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide (CID 98442536) is 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide.
What is the SMILES notation for 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide?
The canonical SMILES for 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide is COc1ccc(C(=O)N(CC(=O)N2CCN(c3ccc(-c4ccc(C)cc4)nn3)CC2)[C@@H](C)c2ccccc2)cc1.
What is the InChIKey of 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide?
The InChIKey is KRSDRRVVBOOERJ-VWLOTQADSA-N. The full InChI is InChI=1S/C33H35N5O3/c1-24-9-11-27(12-10-24)30-17-18-31(35-34-30)36-19-21-37(22-20-36)32(39)23-38(25(2)26-7-5-4-6-8-26)33(40)28-13-15-29(41-3)16-14-28/h4-18,25H,19-23H2,1-3H3/t25-/m0/s1.
What are the key properties of 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide?
4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide has a molecular weight of 549.68 g/mol, XLogP of 5.01, 8 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 4-methoxy-N-[2-[4-[6-(4-methylphenyl)pyridazin-3-yl]piperazin-1-yl]-2-oxoethyl]-N-[(1S)-1-phenylethyl]benzamide is sourced from PubChem (CID 98442536), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).